Biologic Therapy Market Research Report: Information By Product Type (Kits & Reagents, and Services), By Therapy (Protein Therapy and Vaccine Therapy), By Application (Cellular and Gene Therapy), By End Users), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

ID: MRFR/LS/0344-HCR | 105 Pages | Published By Rahul Gotadki on March 2023

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Biologic Therapy Market, by Product Type

6.1 Introduction

6.2 Kits & Reagents

6.2.1 Market Estimates & Forecast, 2023-2030

6.3 Services

6.3.1 Market Estimates & Forecast, 2023-2030

6.4 Instruments

6.4.1 Market Estimates & Forecast, 2023-2030

7. Global Biologic Therapy Market, by Therapy

7.1 Introduction

7.2 Protein Therapy

7.2.1 Market Estimates & Forecast, 2023-2030

7.3 Vaccines Therapy

7.3.1 Market Estimates & Forecast, 2023-2030

7.4 Cell Therapy

7.4.1 Market Estimates & Forecast, 2023-2030

7.5 Others

7.5.1 Market Estimates & Forecast, 2023-2030

8. Global Biologic Therapy Market, by Application

8.1 Introduction

8.2 Vaccine & Therapeutics Development

8.2.1 Market Estimates & Forecast, 2023-2030

8.3 Blood and Blood-Related Products Testing

8.3.1 Market Estimates & Forecast, 2023-2030

8.4 Cellular and Gene Therapy

8.4.1 Market Estimates & Forecast, 2023-2030

8.4 Tissue and Tissue-Related Products Testing

8.4.1 Market Estimates & Forecast, 2023-2030

8.4 Stem Cell Research

8.4.1 Market Estimates & Forecast, 2023-2030

9. Global Biologic Therapy Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

9.2.1 Market Estimates & Forecast, 2023-2030

9.3 Specialty Centers

9.3.1 Market Estimates & Forecast, 2023-2030

9.4 Research Centers

9.4.1 Market Estimates & Forecast, 2023-2030

10 Global Biologic Therapy Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K.

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Amgen Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Bristol-Myers Squibb

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Celgene Corporation

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 F. Hoffmann-La Roche AG

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Novartis International AG

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 GlaxoSmithKline Plc

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Seattle Genetics, Inc.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix

LIST OF TABLES

Table 1 Prescribed Biologic Therapy Industry Synopsis, 2023-2030

Table 2 Global Biologic Therapy Market Estimates and Forecast, 2023-2030, (USD Million)

Table 3 Global Biologic Therapy Market, by Region, 2023-2030, (USD Million)

Table 5 Global Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 6 Global Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 7 Global Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 8 North America Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 9 North America Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 10 North America Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 11 US Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 12 US Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 13 US Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 14 Canada Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 15 Canada Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 16 Canada Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 17 South America Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 18 South America Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 19 South America Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 20 Europe Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 21 Europe Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 22 Europe Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 23 Western Europe Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 24 Western Europe Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 25 Western Europe Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 26 Eastern Europe Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 27 Eastern Europe Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 28 Eastern Europe Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 29 Asia Pacific Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 30 Asia Pacific Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 31 Asia Pacific Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

Table 32 Middle East & Africa Biologic Therapy Market, by Type, 2023-2030, (USD Million)

Table 33 Middle East & Africa Biologic Therapy Market, by Application, 2023-2030, (USD Million)

Table 34 Middle East & Africa Biologic Therapy Market, by End-User, 2023-2030, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Biologic Therapy Market

Figure 3 Segmentation Market Dynamics for Biologic Therapy Market

Figure 4 Global Biologic Therapy Market Share, by Type 2023

Figure 5 Global Biologic Therapy Market Share, by Application 2023

Figure 6 Global Biologic Therapy Market Share, by End-User, 2023

Figure 7 Global Biologic Therapy Market Share, by Region, 2023

Figure 8 North America Biologic Therapy Market Share, by Country, 2023

Figure 9 Europe Biologic Therapy Market Share, by Country, 2023

Figure 10 Asia Pacific Biologic Therapy Market Share, by Country, 2023

Figure 11 Middle East & Africa Biologic Therapy Market Share, by Country, 2023

Figure 12 Global Biologic Therapy Market: Company Share Analysis, 2023 (%)

Figure 13 Amgen Inc.: Key Financials

Figure 14 Amgen Inc.: Segmental Revenue

Figure 16 Amgen Inc.: Geographical Revenue

Figure 17 Celgene Corporation: Key Financials

Figure 18 Celgene Corporation: Segmental Revenue

Figure 19 Celgene Corporation: Geographical Revenue

Figure 20 Novartis International AG: Key Financials

Figure 21 Novartis International AG Segmental Revenue

Figure 22 Novartis International AG: Geographical Revenue

Figure 23 Seattle Genetics, Inc.: Key Financials

Figure 24 Seattle Genetics, Inc.: Segmental Revenue

Figure 25 Seattle Genetics, Inc.: Geographical Revenue

Figure 26 Spectrum Pharmaceuticals, Inc.: Key Financials

Figure 27 Spectrum Pharmaceuticals, Inc.: Segmental Revenue

Figure 28 Spectrum Pharmaceuticals, Inc.: Geographical Revenue

Figure 29 GlaxoSmithKline Plc. Key Financials

Figure 30 GlaxoSmithKline Plc. Segmental Revenue

Figure 31 GlaxoSmithKline Plc. Geographical Revenue

Figure 32 Stryker: Key Financials

Figure 33 Stryker: Segmental Revenue

Figure 34 Stryker: Geographical Revenue

Biologic Therapy Market Segmentation

Biologic Therapy Product Type Outlook (USD Billion, 2019-2030)

Kits & Reagents

Services

Biologic Therapy Therapy Outlook (USD Billion, 2019-2030)

Protein Therapy

Vaccines Therapy

Biologic Therapy Application Outlook (USD Billion, 2019-2030)

Cellular

Gene Therapy

Biologic Therapy End User Outlook (USD Billion, 2019-2030)

Hospitals

Clinics

Specialty Centers

Biologic Therapy Regional Outlook (USD Billion, 2019-2030)

North America Outlook (USD Billion, 2019-2030)
- North America Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- North America Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- North America Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- North America Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- US Outlook (USD Billion, 2019-2030)
- US Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- US Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- US Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- US Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- CANADA Outlook (USD Billion, 2019-2030)
- CANADA Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- CANADA Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- CANADA Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- CANADA Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers

Europe Outlook (USD Billion, 2019-2030)
- Europe Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Europe Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Europe Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Europe Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- Germany Outlook (USD Billion, 2019-2030)
- Germany Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Germany Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Germany Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Germany Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- France Outlook (USD Billion, 2019-2030)
- France Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- France Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- France Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- France Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- UK Outlook (USD Billion, 2019-2030)
- UK Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- UK Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- UK Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- UK Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- ITALY Outlook (USD Billion, 2019-2030)
- ITALY Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- ITALY Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- ITALY Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- ITALY Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- SPAIN Outlook (USD Billion, 2019-2030)
- Spain Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Spain Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Spain Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Spain Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- Rest of Europe Outlook (USD Billion, 2019-2030)
- Rest of Europe Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- REST OF EUROPE Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- REST OF EUROPE Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- REST OF EUROPE Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers

Asia-Pacific Outlook (USD Billion, 2019-2030)
- Asia-Pacific Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Asia-Pacific Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Asia-Pacific Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Asia-Pacific Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- China Outlook (USD Billion, 2019-2030)
- China Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- China Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- China Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- China Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- Japan Outlook (USD Billion, 2019-2030)
- Japan Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Japan Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Japan Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Japan Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- India Outlook (USD Billion, 2019-2030)
- India Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- India Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- India Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- India Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- Australia Outlook (USD Billion, 2019-2030)
- Australia Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Australia Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Australia Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Australia Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
- Rest of Asia-Pacific Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Rest of Asia-Pacific Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Rest of Asia-Pacific Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Rest of Asia-Pacific Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers

Rest of the World Outlook (USD Billion, 2019-2030)
- Rest of the World Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Rest of the World Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Rest of the World Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Rest of the World Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- Middle East Outlook (USD Billion, 2019-2030)
- Middle East Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Middle East Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Middle East Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Middle East Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- Africa Outlook (USD Billion, 2019-2030)
- Africa Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Africa Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Africa Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Africa Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers
- Latin America Outlook (USD Billion, 2019-2030)
- Latin America Biologic Therapy by Product Type
  - Kits & Reagents
  - Services
- Latin America Biologic Therapy by Therapy
  - Protein Therapy
  - Vaccines Therapy
- Latin America Biologic Therapy by Application
  - Cellular
  - Gene Therapy
- Latin America Biologic Therapy by End User
  - Hospitals
  - Clinics
  - Specialty Centers